We are live on
!
Find out more
Arcturus Therapeutics
ARCT
ARCT
18 hedge funds and large institutions have $6.98M invested in Arcturus Therapeutics in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
89% more capital invested
Capital invested by funds: $3.69M → $6.98M (+$3.29M)
1.37% more ownership
Funds ownership: 6.28% → 7.65% (+1.4%)
0% more funds holding
Funds holding: 18 → 18 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
91% less call options, than puts
Call options by funds: $2K | Put options by funds: $22K
Holders
18
Holders Change
–
Holders Change %
0%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
2
Closed
5
Calls
$2K
Puts
$22K
Net Calls
-$20K
Net Calls Change
-$20K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.31M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$171K |
| 3 |
BlackRock
New York
|
+$129K |
| 4 |
Morgan Stanley
New York
|
+$90.4K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
+$82.9K |
